Innovative device maintains IOL stability, prevents posterior capsule opacification





September 23, 2022

1 min watch

Source/Disclosures

Source:

Pallikaris I. Eye PCR. Presented at: European Society of Cataract and Refractive Surgeons meeting; Sept. 16-20, 2022; Milan.

Disclosures:
Pallikaris reports being the founder of Eye PCR.


We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

MILAN — In this video from the ESCRS meeting, Ioannis Pallikaris, MD, PhD, speaks about a device of his own invention presented during the iNovation Day special session.

Fixoflex (Eye PCR) is a unique ophthalmic implant designed to maintain a consistent and stable environment for IOL placement, minimizing tilt and decentration. It has also shown the ability to close off cell migration, preventing formation of posterior capsule opacification. Additionally, it eliminates dysphotopsia and facilitates lens replacement.

The device has completed the clinical trials phase and is ready to receive the CE mark.




Leave a Reply

Your email address will not be published.